Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies.
Keep in mind US manufacturer pump indication: ages 2+. Control-IQ+ type 1 indication is ages 2+ and type 2 indication ages 18+; CGM age limits can be different.
Tubeless insulin pod automates delivery from compatible CGM readings through an app or controller.
Keep in mind Compatibility is system, firmware and market dependent. No dosing or treatment recommendation is made.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model |  |  |
|---|---|---|
| Prices · all markets | Price not verified 0 offer records & sourcesNo verified price in this audit. | Price not verified 0 offer records & sourcesNo verified price in this audit. |
| Designed for | Prescription subcutaneous insulin delivery; regional Control-IQ+ eligibility applies. ↗ | Tubeless insulin pod automates delivery from compatible CGM readings through an app or controller. ↗ |
| Form factor | Touchscreen wearable insulin pump with infusion tubing ↗ | Wearable disposable insulin Pod ↗ |
| Power & output | Rechargeable battery ↗ | Not verified |
| Water / dust rating | Not verified | Pod IP28, up to 25 ft for 60 min; controller not waterproof ↗ |
| Software | In-warranty software updates subject to eligibility/training ↗ | Not verified |
| Reservoir | 300 units ↗ | Not applicable to this category |
| Control | Colour touchscreen; compatible mobile bolus option ↗ | Not applicable to this category |
| Profiles | Up to six personal profiles with timed segments ↗ | Not applicable to this category |
| Cgms | Maker currently lists Dexcom G7 systems and FreeStyle Libre 3 Plus; configuration dependent ↗ | Not applicable to this category |
| Algorithm | Control-IQ+ ↗ | Not applicable to this category |
| Wear Duration | Not applicable to this category | Up to 72 hours ↗ |
| Capacity | Not applicable to this category | Up to 200 units U-100 rapid-acting insulin ↗ |
| Dosing | Not applicable to this category | Automatic adjustments every five minutes ↗ |
| USIndication | Not applicable to this category | Type 1 diabetes ages 2+; type 2 diabetes ages 18+ ↗ |
| Controller | Not applicable to this category | Compatible smartphone app or supplied controller ↗ |
| CGM | Not applicable to this category | Dexcom G7 systems, Libre 3 Plus and Libre 2 Plus per current US page ↗ |
| Target Glucose | Not applicable to this category | US page lists customizable 100-150 mg/dL ↗ |
| Availability | Exact manufacturer model verified; market and purchase eligibility follow the linked manufacturer source. | Prescription/benefits check and compatible CGM required; pharmacy access varies by coverage. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | No editorial ranking recorded |
| Evidence | Manufacturer source Checked 2026-10-12 | Manufacturer source Checked 2026-10-13 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.
